| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human RTKN2 recombinant protein (Position: M1-D572) was used as the immunogen for the RTKN2 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
RTKN2 Antibody / Rhotekin 2 is a anti-RTKN2 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as ELISA, Flow cytometry (FACS), Western blot (WB) with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: RTKN2
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): ELISA, FACS, WB
Biological background
Functionally, RTKN2 antibody identifies a 646-amino-acid cytoplasmic protein containing a Rho-binding domain (RBD) and ankyrin repeats that mediate protein-protein interactions. RTKN2 binds active GTP-bound RhoA to stabilize cytoskeletal structures and prevent apoptotic signaling. It also influences NF-kappaB activation and transcriptional regulation of immune and inflammatory genes. In T lymphocytes, RTKN2 promotes cell survival and proliferation by integrating RhoA and anti-apoptotic signaling pathways.
The RTKN2 gene is located on chromosome 10q21.1 and is highly expressed in lymphoid tissues, testis, and brain. Expression increases during T-cell activation and stress responses, indicating roles in immune signaling and cytoskeletal adaptation. RTKN2 contributes to both structural stability and signaling plasticity within dynamic cellular environments.
Pathologically, RTKN2 has been implicated in cancer and autoimmune disease. Overexpression enhances survival and proliferation of cancer cells through activation of NF-kappaB and suppression of apoptosis, whereas reduced RTKN2 expression may impair lymphocyte function and stress resistance. Research using RTKN2 antibody supports studies in Rho GTPase signaling, cytoskeletal dynamics, and immune cell regulation.
RTKN2 antibody is validated for western blotting, immunofluorescence, and immunohistochemistry to detect Rho effector proteins.
Structurally, Rhotekin 2 consists of a central RhoA-binding domain, ankyrin repeats, and multiple phosphorylation sites that control its localization and interaction with downstream effectors. Its structure enables binding to GTP-bound RhoA and integration with cell survival pathways. This antibody facilitates analysis of RTKN2's role in Rho-dependent signaling and immune cell function.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
